Nifty Smallcap 100 News and Updates

Name: Latest research reports of Sagility India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Sagility India Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on Nifty Smallcap 100 from all sources in a single place.

Load latest

Kaynes Technology India Ltd.

16 May 2025

5932.50

-0.31%

Kaynes Technology India Results Earnings Call for Q4FY25 & Full Year

Conference Call with Kaynes Technology India Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Inventurus Knowledge Solutions Ltd.

16 May 2025

1557.20

-1.44%

Inventurus Knowledge Solutions Results Earnings Call for Q4FY25 & Full Year

Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Crompton Greaves Consumer Electricals Ltd.

16 May 2025

346.00

-0.87%

Crompton Greaves Consumer Electricals Q4 Review: Jefferies, CLSA Optimistic On Strong Margin

NDTV Profit

Jefferies expects 14% compound growth sales over fiscals 2025 to 2028 while CLSA sees margin gains as the key catalyst for stock re-rating.

ICICI Securities Limited decreased Buy price target of Crompton Greaves Consumer Electricals Ltd. to 420.0 on 16 May, 2025.

Sagility India Ltd.

16 May 2025

43.59

-1.45%

Guidance intact; resiliency on display

Buy: Sagility India Ltd.

ICICI Securities Limited

Sagility India reported 5.8% QoQ USD revenue growth (organic growth at 0.7%), slightly ahead of I-Sec estimate in Q4FY25. It met its guidance of delivering mid-teens growth in FY25 with 15% YoY USD print.

Number of MF schemes increased from 9 to 18 in Mar 2025 qtr.

CESC Ltd.

16 May 2025

168.21

-2.16%

Changes in regulatory environment; renewable shoots begin to take root

Buy: CESC Ltd.

Target

ICICI Securities Limited

CESC has arrested the build-up of regulatory assets in the Kolkata distribution area, addressing a major overhang on the stock. It has taken two hikes in fuel and power purchase which has augmented its cashflow.

Number of FII/FPI investors decreased from 260 to 230 in Mar 2025 qtr

Crompton Greaves Consumer Electricals Ltd.

16 May 2025

346.00

-0.87%

Strong revival in profitability of Butterfly drives EVA creation upwards

Buy: Crompton Greaves Consumer ...

Target

ICICI Securities Limited

Crompton reported a strong set of numbers in Q4FY25. There is revival in revenue growth as well as profitability of Butterfly. It was a drag on consolidated earnings over past seven quarters.

ICICI Securities Limited decreased Buy price target of Crompton Greaves Consumer Electricals Ltd. to 420.0 on 16 May, 2025.

Nuvama Wealth Management Ltd.

15 May 2025

6802.00

-1.35%

Fund managers lapped up IT stocks in April after index correction

Business Standard

As per an analysis by Nuvama Alternative & Quantitative Research, companies in the information technology (IT) sector found favour among fund managers following a sharp correction in the IT index

Nuvama Wealth Management Ltd. is trading above all available SMAs

Godfrey Phillips India Ltd.

15 May 2025

8324.50

-2.67%

Godfrey Phillips Q4 results: Profit up 30% at 279.61 cr, expenses down 43%

Business Standard

Revenue from customer contracts rose 74% in Q4FY25; company declared 3,000% final dividend as annual profit rose over 21% and expenses saw significant decline

Number of FII/FPI investors increased from 177 to 184 in Mar 2025 qtr.

Godfrey Phillips Q4 Results: Profit Up 30%; Dividend Of Rs 60 Announced

NDTV Profit | 15 May 2025

Piramal Pharma Ltd.

15 May 2025

206.32

0.08%

Piramal Pharma expects single-digit growth in FY26 amid uncertainties

Business Standard

PPL projects a muted FY26 due to global headwinds but aims to double its India consumer health business turnover to Rs 2,000 crore by FY30 through scale and expansion

Piramal Pharma Ltd. has an average target of 252.20 from 5 brokers.

Neuland Laboratories Ltd.

15 May 2025

11193.00

-0.01%

Neuland Laboratories Results Earnings Call for Q4FY25 & Full Year

Conference Call with Neuland Laboratories Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Is Nifty Smallcap 100 worth buying?

302 Votes:

Buy 73.84%

Sell 17.55%

Hold 8.61%

Nifty Smallcap 100 PB	4.3
Nifty Smallcap 100 PE	31.2
Nifty Smallcap 100 DIV	0.8
Nifty Smallcap 100 EPS	563.4